Topiramate for Tobacco Dependence in Patients with Depression
Author Information
Author(s): Campayo Javier García, Sobradiel Natalia, Alda Marta, Mas Adoración, Andrés Eva, Magallón Rosa, Crucelaegui Arantxa, Sanz Beatriz
Primary Institution: Servicio de Psiquiatría, Hospital Miguel Servet y Universidad de Zaragoza, Spain
Hypothesis
Is topiramate as effective as standard nicotine substitution therapy for tobacco cessation in patients with depression?
Conclusion
Topiramate may be an effective alternative for tobacco cessation in patients with depression.
Supporting Evidence
- Topiramate has shown promise in treating tobacco dependence in preliminary studies.
- Patients with depression have higher rates of tobacco dependence compared to the general population.
- The study aims to provide a new pharmacological option for tobacco cessation in psychiatric patients.
Takeaway
This study is trying to find out if a medicine called topiramate can help people with depression stop smoking, just like other common treatments.
Methodology
A randomised, controlled trial comparing topiramate with nicotine substitution therapy in patients with depression across 29 primary care health centres.
Limitations
Potential difficulties in recruitment due to lack of motivation for tobacco cessation in psychiatric patients.
Participant Demographics
Patients aged 18–65 years, diagnosed with major depression, smoking more than 20 cigarettes/day.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website